Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Inventory (2023 - 2025)

Krystal Biotech's Change in Inventory history spans 3 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 83.78% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $6.3 million, down 47.21%, while the annual FY2025 figure was $6.3 million, 47.21% down from the prior year.
  • Change in Inventory for Q4 2025 was $1.1 million at Krystal Biotech, down from $4.7 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $6.5 million in Q4 2024 and bottomed at -$880000.0 in Q2 2025.
  • The 3-year median for Change in Inventory is $1.4 million (2025), against an average of $2.1 million.
  • The largest YoY upside for Change in Inventory was 1225.41% in 2024 against a maximum downside of 158.5% in 2024.
  • A 3-year view of Change in Inventory shows it stood at $492000.0 in 2023, then soared by 1225.41% to $6.5 million in 2024, then crashed by 83.78% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Change in Inventory are $1.1 million (Q4 2025), $4.7 million (Q3 2025), and -$880000.0 (Q2 2025).